Development of effective biomarkers for the diagnosis and prognosis of Prostate Cancer [ 2015 - 2017 ]

Research Grant

Researchers: Prof Douglas Brooks (Principal investigator) ,  A/Pr Lisa Butler

Brief description Every year ~20,000 Australian men are diagnosed with prostate cancer and more than 3,000 die of this disease. The current PSA test for the diagnosis of prostate cancer is not specific and this can result in incorrect diagnosis, unnecessary biopsies and lead to wrong treatments. We have discovered a novel change in the biology of prostate cancer. We will use this information to develop new tests for prostate cancer, which provide early accurate detection and can predict disease progression.

Funding Amount $AUD 1,062,585.89

Funding Scheme Development Grants

Notes Development Grant